The Peritoneal Dialysis Set industry trends over the past 18 months have been shaped by innovation and strategic collaborations. Key players like Fresenius Medical Care and Baxter International have strengthened their market presence through partnerships with digital health firms, integrating IoT-enabled monitoring systems into PD sets to enhance patient compliance and remote care. In mergers & acquisitions, Baxter’s 2023 acquisition of a biocompatible material startup underscored the sector’s focus on reducing peritoneal inflammation risks. Product/technology launches have accelerated, with companies such as Asahi Kasei introducing antimicrobial-coated sets and B. Braun launching compact, user-friendly PD systems for home use. Regulatory shifts, including the FDA’s 2023 update to sterilization protocols, have driven manufacturers to adopt advanced ethylene oxide-free methods, while the EU’s MDR compliance deadlines reshaped CE-marking processes. A shift in consumer trends toward home dialysis, fueled by cost efficiency and convenience, has spurred demand for disposable, pre-connected PD sets. Funding rounds in 2024, particularly for Asian startups like Nikkiso and Medtronic Asia, highlight growing investment in AI-driven PD analytics and regional market expansion. These developments signal a transformative phase for the Peritoneal Dialysis Set industry trends, emphasizing technology-driven care and global accessibility.
